Latest Insider Transactions at Dermata Therapeutics, Inc. (DRMA)
This section provides a real-time view of insider transactions for Dermata Therapeutics, Inc. (DRMA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Dermata Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Dermata Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 06
2022
|
Andrew Seth Sandler |
BUY
Grant, award, or other acquisition
|
Direct |
10,120
+29.5%
|
-
|
|
Oct 06
2022
|
David F Hale |
BUY
Grant, award, or other acquisition
|
Direct |
30,155
+28.48%
|
-
|
|
Oct 06
2022
|
Mary Fisher |
BUY
Grant, award, or other acquisition
|
Direct |
9,810
+29.5%
|
-
|
|
Oct 06
2022
|
Kathleen D. Scott |
BUY
Grant, award, or other acquisition
|
Direct |
11,359
+29.5%
|
-
|
|
Oct 06
2022
|
Wendell Wierenga |
BUY
Grant, award, or other acquisition
|
Direct |
20,654
+24.87%
|
-
|
|
Oct 06
2022
|
Brittany Bradrick |
BUY
Grant, award, or other acquisition
|
Direct |
9,810
+29.5%
|
-
|
|
Jul 07
2022
|
Andrew Seth Sandler |
BUY
Grant, award, or other acquisition
|
Direct |
8,874
+38.69%
|
-
|
|
Jul 07
2022
|
David F Hale |
BUY
Grant, award, or other acquisition
|
Direct |
26,441
+36.72%
|
-
|
|
Jul 07
2022
|
Kathleen D. Scott |
BUY
Grant, award, or other acquisition
|
Direct |
9,960
+38.69%
|
-
|
|
Jul 07
2022
|
Wendell Wierenga |
BUY
Grant, award, or other acquisition
|
Direct |
18,110
+30.26%
|
-
|
|
Jul 07
2022
|
Mary Fisher |
BUY
Grant, award, or other acquisition
|
Direct |
8,602
+38.69%
|
-
|
|
Jul 07
2022
|
Brittany Bradrick |
BUY
Grant, award, or other acquisition
|
Direct |
8,602
+38.69%
|
-
|
|
Apr 07
2022
|
David F Hale |
BUY
Grant, award, or other acquisition
|
Direct |
15,466
+44.71%
|
-
|
|
Apr 07
2022
|
Brittany Bradrick |
BUY
Grant, award, or other acquisition
|
Direct |
5,031
+50.0%
|
-
|
|
Apr 07
2022
|
Andrew Seth Sandler |
BUY
Grant, award, or other acquisition
|
Direct |
5,190
+50.0%
|
-
|
|
Apr 07
2022
|
Kathleen D. Scott |
BUY
Grant, award, or other acquisition
|
Direct |
5,826
+50.0%
|
-
|
|
Apr 07
2022
|
Mary Fisher |
BUY
Grant, award, or other acquisition
|
Direct |
5,031
+50.0%
|
-
|
|
Apr 07
2022
|
Wendell Wierenga |
BUY
Grant, award, or other acquisition
|
Direct |
10,593
+40.64%
|
-
|
|
Nov 23
2021
|
Gerald T Proehl President, CEO and Chairman |
BUY
Open market or private purchase
|
Direct |
20,000
+25.15%
|
$40,000
$2.4 P/Share
|
|
Aug 17
2021
|
Christopher J. Nardo Senior VP, CDO |
BUY
Conversion of derivative security
|
Indirect |
2,439
+50.0%
|
-
|
|
Aug 17
2021
|
Thomas Insley Chief Financial Officer |
BUY
Conversion of derivative security
|
Indirect |
4,581
+24.22%
|
-
|
|
Aug 17
2021
|
Wendell Wierenga |
BUY
Conversion of derivative security
|
Direct |
8,163
+38.5%
|
-
|
|
Aug 17
2021
|
Proehl Investment Ventures LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,988,227
+14.67%
|
-
|
|
Aug 17
2021
|
David F Hale |
BUY
Open market or private purchase
|
Indirect |
35,714
+50.0%
|
-
|
|
Aug 17
2021
|
David F Hale |
BUY
Conversion of derivative security
|
Indirect |
278,291
+10.58%
|
-
|
|
Aug 17
2021
|
Munera Maria E Bedoya Toro SVP, Regulatory Affairs |
BUY
Conversion of derivative security
|
Indirect |
64,631
+19.05%
|
-
|
|
Aug 17
2021
|
Gerald T Proehl President, CEO and Chairman |
BUY
Open market or private purchase
|
Indirect |
142,857
+48.31%
|
-
|
|
Aug 17
2021
|
Gerald T Proehl President, CEO and Chairman |
BUY
Conversion of derivative security
|
Indirect |
2,050,779
+27.92%
|
-
|
|
Aug 16
2021
|
Gerald T Proehl President, CEO and Chairman |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$40,000
$4.96 P/Share
|